Israeli-developed cancer drug receives FDA approval - US & World News

Israeli-developed cancer drug receives FDA approval

Israel Hayom | Exclusive to | Posted: Wednesday, October 25, 2017 8:39 am

Kite Pharma, founded by Israeli-American professor Arie Belldegrun in 2009, announced that the U.S. Food and Drug Administration (FDA) has granted regular approval for its cancer treatment, Yescarta.

The product, which the FDA approved on a fast-track process, is based on innovative technology that recruits the body’s immune system to identify and destroy cancer cells.

Login required

We have used your information to see if you have a subscription with us, but did not find one.

Please click the button below to verify an existing account or to purchase a new subscription.

Need an account? Create one now.

You must login to view the full content on this page.